Can Celcuity Climb 87.59 percent to Reach the Level Wall Street Analysts Expect?
CELC Stock | USD 13.05 0.85 6.12% |
About 66% of Celcuity LLC's investor base is looking to short. The analysis of the overall investor sentiment regarding Celcuity LLC suggests that many traders are alarmed. The current market sentiment, together with Celcuity LLC's historical and current headlines, can help investors time the market. In addition, many technical investors use Celcuity LLC stock news signals to limit their universe of possible portfolio assets.
Celcuity |
The consensus price target hints at an 87.6 percent upside potential for Celcuity . While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read at finance.yahoo.com
Celcuity LLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Celcuity LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Celcuity LLC Fundamental Analysis
We analyze Celcuity LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celcuity LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celcuity LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Celcuity LLC is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Celcuity LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celcuity LLC stock to make a market-neutral strategy. Peer analysis of Celcuity LLC could also be used in its relative valuation, which is a method of valuing Celcuity LLC by comparing valuation metrics with similar companies.
Peers
Celcuity LLC Related Equities
ANAB | AnaptysBio | 4.77 | ||||
ANTX | AN2 Therapeutics | 3.73 | ||||
CSBR | Champions Oncology | 3.59 | ||||
ACRV | Acrivon Therapeutics, | 2.65 | ||||
MNOV | MediciNova | 1.46 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
MOLN | Molecular Partners | 0.53 | ||||
EWTX | Edgewise Therapeutics | 0.31 | ||||
IKNA | Ikena Oncology | 1.16 | ||||
MLYS | Mineralys Therapeutics, | 1.42 | ||||
RZLT | Rezolute | 1.44 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
ADAG | Adagene | 2.20 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
CCCC | C4 Therapeutics | 4.34 |
Complementary Tools for Celcuity Stock analysis
When running Celcuity LLC's price analysis, check to measure Celcuity LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celcuity LLC is operating at the current time. Most of Celcuity LLC's value examination focuses on studying past and present price action to predict the probability of Celcuity LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celcuity LLC's price. Additionally, you may evaluate how the addition of Celcuity LLC to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |